Logotype for Compagnia dei Caraibi S.p.A.

Compagnia dei Caraibi (TIME) H1 2025 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for Compagnia dei Caraibi S.p.A.

H1 2025 earnings summary

2 Jun, 2026

Executive summary

  • Revenue for H1 2025 was €21.0 million, down 25.5–34.3% year-over-year due to the loss of key distribution agreements, exit of two spirits brands, and B2B sales decline in Italy.

  • EBITDA was negative at €-1.2 million (margin -5.8%), and net loss deepened to €2.4 million from €1.86 million in H1 2024.

  • The group underwent significant restructuring, including cost rationalization, integration of subsidiaries, staff reductions, and a focus on brand building and omnichannel strategies.

  • Net financial position was negative €10.4 million, slightly improved from year-end 2024.

  • Shareholders’ equity turned negative at €-0.64 million (from €1.56 million at end-2024).

Financial highlights

  • Revenues fell from €28.2 million in H1 2024 to €21.0 million in H1 2025.

  • EBITDA margin declined to -5.8% from -2.5% year-over-year.

  • EBIT margin dropped to -9.7% from -5.0% in H1 2024; net loss reached €2.42 million.

  • Net financial position improved slightly to €-10.4 million from €-11.0 million at year-end 2024.

  • Cash liquidity at period end was €1.0 million, down from €1.8 million at 2024 year-end.

Outlook and guidance

  • Management expects a progressive recovery in margins in H2 2025, supported by cost efficiencies, new partnerships, and brand launches.

  • The group remains focused on strengthening its brand portfolio, expanding digital B2B channels, and enhancing B2C presence.

  • Signs of business recovery observed in September, with expectations to reduce losses by year-end.

  • Forecasts depend on successful refinancing, new product integration, and market recovery.

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more